Sweeney Jennifer, Parikh Nainesh, El-Haddad Ghassan, Kis Bela
Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center, Tampa, Florida.
Semin Intervent Radiol. 2019 Oct;36(4):298-302. doi: 10.1055/s-0039-1696649. Epub 2019 Oct 31.
Intrahepatic cholangiocarcinoma is the second most common primary liver cancer but represents only a small portion of all primary liver cancers. At the time of diagnosis, patients are often not surgical candidates due to tumor burden of other comorbidities. In addition, there is a very high rate of tumor recurrence after resection. Local regional therapies, specifically ablative therapies of radiofrequency ablation, microwave ablation, cryoablation, and irreversible electroporation, have proven to be beneficial with other hepatic tumors. The purpose of this review is to provide an overview and update of the medical literature demonstrating ablative therapy as a treatment option for intrahepatic cholangiocarcinoma.
肝内胆管癌是第二常见的原发性肝癌，但在所有原发性肝癌中所占比例较小。在诊断时，由于肿瘤负荷或其他合并症，患者往往不适合手术。此外，切除术后肿瘤复发率非常高。局部区域治疗，特别是射频消融、微波消融、冷冻消融和不可逆电穿孔等消融治疗，已被证明对其他肝脏肿瘤有益。本综述的目的是概述和更新医学文献，证明消融治疗是肝内胆管癌的一种治疗选择。
